Low HDL Market for RVX It was discussed today what is the potential market for RVX if they are limited to low HDL patients only.
The answer is still a very large number.
RVX estimates that there are 12.5 million High Risk Vascular Disease with low HDL in the United States.
In the top 7 markets world wide that number is 25 million.